Biofrontera (BFRI)
NASDAQ:BFRI
Holding BFRI?
Track your performance easily

Biofrontera (BFRI) Financial Statements

113 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently ―. The company's EPS TTM is $-5.923; its P/E ratio is -0.22; Biofrontera is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Mar 23
Income Statement-
Total Revenue$ 7.84M$ 7.91M$ 10.59M$ 8.90M$ 8.73M
Gross Profit$ 7.84M$ 7.91M$ 5.66M$ 4.33M$ 4.16M
EBIT$ 359.00K$ -3.54M-$ -6.20M$ -7.44M
EBITDA$ 659.00K$ -3.25M-$ -6.20M$ -7.18M
Net Income Common Stockholders$ -257.00K$ -10.44M$ 3.53M$ -6.34M$ -7.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.38M$ 3.82M$ 1.34M$ 3.42M$ 21.10M
Total Assets$ 21.57M$ 24.57M$ 27.93M$ 34.10M$ 41.97M
Total Debt$ 1.44M$ 3.67M$ 5.40M$ 2.81M$ 1.21M
Net Debt$ -2.94M$ -151.00K$ 4.06M$ -608.00K$ -19.89M
Total Liabilities$ 10.66M$ 26.42M$ 23.14M$ 33.07M$ 25.21M
Stockholders Equity$ 10.91M$ -5.42M$ 4.79M$ 1.04M$ 16.75M
Cash Flow-
Free Cash Flow$ -4.63M$ -3.38M--$ -3.71M
Operating Cash Flow$ -4.67M$ -3.33M$ -8.90M$ -2.00M$ -3.70M
Investing Cash Flow$ -45.00K$ 43.00K$ 73.00K$ 382.00K$ -14.00K
Financing Cash Flow$ 5.28M$ 5.80M$ 6.71M$ 591.00K-
Currency in USD

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis